Alembic Global Holding SA gets USFDA nod for pulmonary arterial hypertension treatment injection

Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic Global Holding SA, has received approval from the US health regulator for its generic Treprostinil injection used for the treatment of pulmonary arterial hypertension.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news